Epsilogen is a global leader in the development of immunoglobulin (IgE) antibodies to treat cancer. IgE has several key features that make it ideal for the treatment of solid tumours including greater potency, enhanced tumour access and a long tissue half-life.


Biotechnology

Epsilogen

Epsilogen's headquarters in London, United Kingdom

Tim Wilson

Ligia Gouveia

Cristina Oliva

José Iglesias

Nick Robbins-Cherry

Leanne Partington

Kevin Fitzgerald

This department manages relationships and communications between the organization and its board members.

Board Relations

This department oversees the management and coordination of clinical activities and processes.

Clinical Operations

This department oversees the strategic direction and leadership in medical and translational science initiatives.

Medical Leadership

This department focuses on conducting scientific research and developing innovative solutions.

Research and Development

The Scientific Team at Epsilogen focuses on the research and development of immunoglobulin (IgE) antibodies for cancer treatment. Team members collaborate to design, engineer, and optimize potent IgE antibodies, leveraging their expertise in phage display, protein science, and advanced scientific methodologies to enhance tumour targeting and improve therapeutic efficacy.

Scientific Team

This department focuses on bridging laboratory research to clinical applications, ensuring effective translation of scientific discoveries into medical practice.

Epsilogen

Org chart

Teams

Board Relations

Clinical Operations

Medical Leadership

Research and Development

Scientific Team

Translational Research

Offices

Epsilogen

Org chart

Teams

Board Relations

Clinical Operations

Medical Leadership

Research and Development

Scientific Team

Translational Research

Offices

Related companies